These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2501268)

  • 1. The killing action of fleroxacin upon Bacteroides fragilis.
    Griggs DJ; Piddock LJ; Wise R
    J Antimicrob Chemother; 1989 Jan; 23(1):53-8. PubMed ID: 2501268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1989; 35(6):423-30. PubMed ID: 2515040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
    Digranes A; Benonisen E; Salveson A; Zahm F
    Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
    Bauernfeind A; Eberlein E; Hörl G
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():81-9. PubMed ID: 3144553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of fleroxacin.
    Georgopoulos A; Breyer S; Georgopoulos M; Mailer H; Graninger W
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():25-9. PubMed ID: 3144544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
    Soussy CJ; Leclercq R; Deforges L; Duval J
    Pathol Biol (Paris); 1989 May; 37(5):364-9. PubMed ID: 2506511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Cooper MA; Andrews JM; Wise R
    J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
    Aldridge KE; Stratton CW
    J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
    Dubreuil L; Devos J; Beerens H; Romond C
    Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.
    Fox AR; Phillips I
    J Antimicrob Chemother; 1987 Oct; 20(4):477-88. PubMed ID: 3680088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich.
    Abeck D; Johnson AP; Alexander F; Korting HC; Ballard RC
    Genitourin Med; 1988 Aug; 64(4):233-4. PubMed ID: 3139546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin.
    van Rensburg CE; Joone G; Anderson R
    Chemotherapy; 1989; 35(4):273-7. PubMed ID: 2504545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.